CarlosArnoldoFierroMD

Medicine/Pediatrics • Kansas City, KS

Physician

Join to view full profile

Dr. Fierro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fierro's full profile

Already have an account?

Office
Clinica Medica
226 N 7th St
Kansas City, KS 66101
Phone+1 913-342-2277

Fax+1 913-342-3662

Education & Training

University of Kansas School of MedicineResidency, Internal Medicine/Pediatrics, 1998 - 2000
University of Kansas School of MedicineClass of 1998

Certifications & Licensure

KS State Medical License 2000 - 2025

Clinical Trials

Panblok H7 Vaccine Adjuvanted With AS03 or MF59 Start of enrollment: 2017 Sep 20
Completed
Phase 2
BARDA Securing Anthrax Immunity For the Elderly Start of enrollment: 2018 May 09
Completed
Phase 2
A Phase 1 Study to Evaluate Safety & Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects Start of enrollment: 2022 Jan 10
Completed
Phase 1
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects Start of enrollment: 2019 Oct 07
Completed
Phase 1
Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines Start of enrollment: 2019 Sep 03
Completed
Phase 1
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers Start of enrollment: 2016 Jun 01
Completed
Phase 1
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults Start of enrollment: 2021 Apr 12
Recruiting
Phase 1
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 Start of enrollment: 2021 Sep 29
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

40 citations
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
Nadine C. Salisch, Kathryn E. Stephenson, Kristi Lynn Williams, Freek Cox, Leslie van der Fits
Annals of Internal Medicine. 2021-02-16
26 citations
Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in olde...
Brandon Essink, Carlos Fierro, Jeffrey Rosen, Amparo L. Figueroa, Bin Zhang
Vaccine. 2020-01-10

Journal Articles

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Karen Kotloff, Stephen A Spector, Carlos Fierro, The New England Journal of Medicine

Press Mentions

Long-Term Studies of COVID-19 Vaccines Hurt by Placebo Recipients Getting ImmunizedFebruary 19th, 2021
‘Historic Achievement’: Local Clinical Research Company Assisted with Promising Moderna COVID-19 TrialNovember 16th, 2020

Other Languages

Spanish

External Links

Clinical Trialshttp://www.jcct.com/